A Study of the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4
Clinical trial NCT02371408 · UNKNOWN
Trial details
- NCT number
- NCT02371408
- Sponsor
- Pharco Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-01-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.